Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
企業コードENOV
会社名Enovis Corp
上場日May 08, 2008
設立日1998
最高経営責任者「CEO」Mr. Damien Mcdonald
従業員数7367
証券種類Ordinary Share
決算期末May 08
本社所在地2711 Centerville Road
都市WILMINGTON
証券取引所NYSE Consolidated
国United States of America
郵便番号19808
電話番号13022529160
ウェブサイトhttps://www.enovis.com/
企業コードENOV
上場日May 08, 2008
設立日1998
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし